Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
about
Rifabutin Is Active against Mycobacterium abscessus Complex.Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells.Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agentRepurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 PathwayIn Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens.Repurposing auranofin for the treatment of cutaneous staphylococcal infections.Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.MRSA decolonization failure-are biofilms the missing link?Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide.Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs.Selenazolinium Salts as "Small Molecule Catalysts" with High Potency against ESKAPE Bacterial Pathogens.The role of toxins in Clostridium difficile infection.Antibacterial Activity and Mechanism of Action of Aspidinol Against Multi-Drug-Resistant Methicillin-Resistant Staphylococcus aureus.Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
P2860
Q33726686-BECFD96B-DE7C-4AE9-97E1-56F727B2D9DDQ35943844-ADCAC6FA-28F1-414C-854D-485A979E0132Q36155799-7A5FA5D5-5CC8-4456-9165-3018DA648152Q36265781-6E1F17EB-C4B2-405D-B3E8-9CEEFB1A19AFQ36266986-0FDABFB7-DFD4-4D5A-BC04-F236B4D9B998Q36278065-1152E60C-5CA0-414D-9528-DF5633BF681EQ36565579-E03CFFF7-BFBC-4912-9F5F-BA03AE36802FQ36689702-9E99A3EE-DE64-4962-B5DD-96BA446AC862Q38673550-59946A48-F565-462F-B1FD-D84166DF6B11Q38865746-5F458C6C-93EF-4AE6-BFE0-DE3C3CA33529Q40607628-0F2B7A91-4244-44C2-9144-895D3671DE04Q41852760-26167A06-C376-4806-A3E4-765978DD6C5AQ47239447-29AC5DB5-5F0E-4F21-9009-66F85EDD93CFQ47734724-9CC320DF-9277-49F3-84BB-2DF06FE81F65Q55440237-31422F4B-496F-460A-AEEF-5B3A5693DCA4Q55514398-7ACD6A7C-FF72-4635-B4B3-8B71324F16D2
P2860
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@ast
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@en
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@nl
type
label
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@ast
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@en
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@nl
prefLabel
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@ast
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@en
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@nl
P2860
P1433
P1476
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
@en
P2093
Shankar Thangamani
Waleed Younis
P2860
P304
P356
10.1371/JOURNAL.PONE.0133877
P407
P577
2015-01-01T00:00:00Z